Capacity Expansion in Tullamore

October 25, 2018

STERIS Laboratories is expanding capacity at our site in Tullamore, Ireland, by building a new state-of-the-art laboratory.

The new laboratory will double the size of the existing laboratory, improve the process flow, and upgrade the overall level of the test areas by adding a Class 6 cleanroom.

It will also allow further expansion, as required by our Customers, with space for new tests to be added.

Planning permission has been obtained and the build has begun, with the laboratory planned to be operational in the second half of 2019.

The expansion of the laboratory follows the installation of a second E-beam facility, the introduction of vaporized hydrogen peroxide (VHP) processing capability, and the addition of extra ethylene oxide processing capacity at the Tullamore site.

Lorraine Moran, STERIS AST Regional Director for Ireland, states: "This expansion is excellent news and supports our commitment to providing both our global and local Customers with processing options."

"It not only ensures the processing capacity for existing and new Customers to grow, but also gives small indigenous Irish Customers the assurance of a sterile solution for their new product developments close to home."

STERIS Tullamore, IE

About STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. 

WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe.

For more information, visit www.steris.com.

 
Related Posts
STERIS Swindon Lab, UK
November 1, 2026

As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS is pleased to announce the launch of MALDI-ToF (Matrix-Assisted Laser Desorption/Ionization Time-of-Flight) identification testing in the United Kingdom.

STERIS AST Research Highlights Considerations for ISO 11137 Dose Validation
October 29, 2026

STERIS Applied Sterilization Technologies (AST) is pleased to announce newly published research examining the effectiveness of industrial gamma and electron beam (E-beam) irradiation in inactivating Bacillus pumilus spores under varying levels of water availability.

STERIS Venlo, NL Facility
October 8, 2026

As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce the completion of the expansion of its existing Venlo, The Netherlands ethylene oxide and X-ray processing facility to include a second X-ray processing line. 

STERIS Alajuela, Costa Rica
September 29, 2026

As part of our long-term commitment to supporting global medical device and pharmaceutical manufacturing, STERIS is pleased to announce the expansion of the laboratory testing capabilities available at our facility in Alajuela, Costa Rica.